Northwest Biotherapeutics (NWBO) Current Leases (2019 - 2026)
Northwest Biotherapeutics' (NWBO) quarterly Current Leases came in at $274000.0 in Q1 2026, down 29.74% year-on-year from $390000.0 in Q1 2025, and down 26.74% quarter-over-quarter from $374000.0 in Q4 2025.
Northwest Biotherapeutics (NWBO) Current Leases (2019 - 2026) Analysis & Trends
Northwest Biotherapeutics' Current Leases history runs 8 years deep, the most recent figure standing at $274000.0 for Q1 2026.
- On a quarterly basis, Current Leases fell 29.74% year-over-year to $274000.0 in Q1 2026; TTM through Mar 2026 was $274000.0, a 29.74% decrease from a year earlier, with the FY2025 full-year figure at $374000.0, up 14.72% from the prior year.
- Current Leases slipped to $274000.0 in Q1 2026 per NWBO's latest filing, from $374000.0 in the prior quarter.
- Across five years, Current Leases topped out at $448000.0 in Q2 2025 and bottomed at $175000.0 in Q2 2024.
- The 5-year median for Current Leases is $334000.0 (2022), against an average of $333294.1.
- Across the five-year window, Current Leases sank 54.55% in 2024 and surged 156.0% in 2025, its largest moves.
- Year by year, Current Leases stood at $354000.0 in 2022, then dropped by 11.3% to $314000.0 in 2023, then climbed by 3.82% to $326000.0 in 2024, then gained by 14.72% to $374000.0 in 2025, then slipped by 26.74% to $274000.0 in 2026.
- Per Business Quant, the three latest NWBO Current Leases figures stand at $274000.0 (Q1 2026), $374000.0 (Q4 2025), and $399000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Northwest Biotherapeutics | 253,653.43 | -1.53 Mn | - | 274,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 274,000.00 |
| Dec 31, 2025 | 374,000.00 |
| Sep 30, 2025 | 399,000.00 |
| Jun 30, 2025 | 448,000.00 |
| Mar 31, 2025 | 390,000.00 |
| Dec 31, 2024 | 326,000.00 |
| Sep 30, 2024 | 256,000.00 |
| Jun 30, 2024 | 175,000.00 |
| Mar 31, 2024 | 245,000.00 |
| Dec 31, 2023 | 314,000.00 |
| Sep 30, 2023 | 369,000.00 |
| Jun 30, 2023 | 385,000.00 |
| Mar 31, 2023 | 369,000.00 |
| Dec 31, 2022 | 354,000.00 |
| Sep 30, 2022 | 334,000.00 |
| Jun 30, 2022 | 329,000.00 |
| Mar 31, 2022 | 325,000.00 |
| Dec 31, 2021 | 317,000.00 |
| Sep 30, 2021 | 305,000.00 |
| Jun 30, 2021 | 249,000.00 |